Amplitude Surgical: Yearly Report on the Liquidity Contract with Natixis

Regulatory News:

Amplitude Surgical (Paris:AMPLI):

Pursuant to the liquidity contract entrusted to Natixis, on 31 December 2015, the following assets appeared on the liquidity account:

• Number of shares: 35,511
• Cash balance of the liquidity account: €320,776

As a reminder, when the contract was implemented on July 27, 2015 the following resources were booked to the liquidity contract:

• €500,000

Next financial press release: H1 2015/16 sales, Wednesday February 3, 2016

About Amplitude Surgical
Founded in 1997 in Valence, France, Amplitude Surgical is a leading French player on the global surgical technology market for lower-limb orthopedics. Amplitude Surgical develops and markets high-end products for orthopedic surgery covering the main disorders affecting the hip, knee and extremities, and notably foot and ankle surgery. Amplitude Surgical develops, in close collaboration with surgeons, numerous high value-added innovations in order to best meet the needs of patients, surgeons and healthcare facilities. A leading player in France, Amplitude Surgical is developing abroad through its subsidiaries and a network of exclusive distributors and agents. Amplitude Surgical operates on the lower-limb market through the intermediary of its Novastep subsidiaries in France and the United States. Amplitude Surgical distributes its products in more than 30 countries. On June 30, 2015, Amplitude Surgical had a workforce of 248 staff and recorded sales of 71.1 million euros and an EBITDA margin of close to 19%.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160115005180/en/